Demographic and Clinical details	No. of patients
Age group:	Total: 282
1. 0-14 years	1. 0
2. 15-25 years	2. 20
3. 26-40 years	3. 58
4. 41-65 years	4. 155
5. >65 years	5. 49
Sex:	Total: 282
1. Male	1. 196
2. Female	2. 86
Indications for ICU admission:	Total: 282
1. Type-I respiratory failure	1. 58
2. Type-II respiratory failure	2. 174
3. Septic shock	3. 45
4. Post-surgery observation	4. 5
Diagnosis:	Total: 282
1. ARDS^a^{, b}	1. 8
2. Bronchial asthma	2. 8
3. Bronchiectasis	3. 3
4. Bullous lung disease	4. 1
5. COPD^d	5. 97
6. Cystic lung disease	6. 1
7. Empyema^a	7. 3
8. Interstitial lung disease^e	8. 19
9. Lung abscess	9. 2
10. Lung cancer^c^{, d}	10. 24
11. Non-tubercular Mycobacterial infection	11. 1
12. Pneumonia^b,c^{, e}	12. 25
13. Post-lung resection surgery	13. 5
14. Post-TB sequelae with obstructive airway disease	14. 69
15. Pulmonary TB	15.21
16. RTA	16.1

Table 1: Demographic and clinical details of the patients.

a - 1 patient had both ARDS and empyema

b - 1 patient had both ARDS and pneumonia

c - 2 patients had both lung cancer and pneumonia

d - 2 patients had both lung cancer and COPD

e - 1 patient had both ILD and pneumonia

Entero- bacterales	Amoxicillin + Clavulinic acid	Cefotax- ime	Ceftazid- ime	Imipen- em	Piperacillin + Tazobactam	Amika- cin	Genta- micin	Ciproflo- xacin	Levoflo- xacin	Doxycy- cline	Cotrimo- xazole	Colistin
E. coli (n = 39)	0	0	64.1	25.64	69.23	69.23	66.67	25.64	30.77	25.64	30.77	94.87
K. pneumoniae (n = 30)	56.67	100	56.67	100	93.33	93.33	26.67	56.67	33.33	100	0	100
Citrobacter spp (n = 27)	0	22.22	22.22	66.67	77.78	11.11	11.11	11.11	11.11	11.11	11.11	100
E. cloacae (n = 3)	0	0	33.33	33.33	0	0	0	0	0	0	0	100
Overall (n = 99)	24.64	0	62.63	34.34	76.77	74.75	21.21	21.21	24.24	24.24	21.74	97.22

Table-2.1: Antibiotic susceptibility profile of major organisms under Enterobacteriaceae group.

Table-2.2: Antibiotic susceptibility profile of major organisms under NFGNB group.

GPCs	Penicillin	Ampicillin	Amoxicillin + Clavulunic acid	Cefox- itin	Azithro- mycin	Clindam- ycin	Gentam- icin	Ciproflox- acin	Levoflox- acin	Doxycy- cline	Cotrimo- xazole	Linezo- lid	Vancom- ycin
S. aureus (n = 24)	0	0	7.5	70.83	29	54	87	25	25	95.83	62.5	100	100
CoNS	0	0	38	28	32	46	78	28	48	70	54	100	100
(n = 50)
E. faecalis (n = 2)	0	0	0	0	0	0	0	0	0	0	0	100	100
Overall	0	0	38.89	43.06	31.08	48.65	81.08	26.32	39.47	84.21	58.12	93.42	100
(n = 76)
MRSA	0	0	0	0	28.57	57.14	0	0	0	85.71	100	100	100
(n = 7)